Skip to main navigation Skip to search Skip to main content

High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma

  • Ann W. Silk
  • , Howard L. Kaufman
  • , Brendan Curti
  • , Janice M. Mehnert
  • , Kim Margolin
  • , David McDermott
  • , Joseph Clark
  • , Jenna Newman
  • , Praveen K. Bommareddy
  • , Lisa Denzin
  • , Saltanat Najmi
  • , Azra Haider
  • , Weichung Shih
  • , Michael P. Kane
  • , Andrew Zloza

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'High-Dose Ipilimumab and High-Dose Interleukin-2 for Patients With Advanced Melanoma'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science